A Clinical Trial of SIBP-A10 Injection in the Treatment of Advanced Malignant Tumor Subjects.

Clinical trial NCT07205198 · RECRUITING

Trial details

NCT number: NCT07205198
Sponsor: Shanghai Institute Of Biological Products
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Tumors

Start date: 2025-10-31
Primary completion: 2028-12-30
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.